Herapy Stem Cell News Today

Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.

Survival in patients who underwent the Ross procedure, a technically complex technique to replace the aortic valve, is 83% after 25 years, which matches that of the general population.

Theres an important opportunity here for regulators to understand there are still quite a number of businesses making problematic advertising claims.

Laurence Faucette lived for 6 weeks after the transplant of a genetically modified pig heart and did well until a few days before his death.

Researchers are exploring HSCT as a rescue therapy in early-stage MS. But theres no consensus on best practices.

The FDA approval was based on a small study, in which 38.9% of patients with relapsed or refractory disease went into complete remission.

Hematologists are heralding a new era in multiple myeloma. Experts discuss how times have changed.

A chemoimmunotherapy and radiation combination without autologous stem cell transplant produced high response rates in children and young adults with low-risk relapsed/refractory Hodgkin lymphoma.

The initiative will ensure the availability of a drug that otherwise would have been abandoned as unprofitable.

The GENESIS trial reported substantially better stem cell mobilization when patients with multiple myeloma received motixafortide alongside filgrastim.